Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD

153  -1.39 (-0.9%)

After market: 156.329 +3.33 (+2.18%)

Fundamental Rating

7

Taking everything into account, LRN scores 7 out of 10 in our fundamental rating. LRN was compared to 73 industry peers in the Diversified Consumer Services industry. LRN gets an excellent profitability rating and is at the same time showing great financial health properties. LRN is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make LRN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year LRN was profitable.
In the past year LRN had a positive cash flow from operations.
LRN had positive earnings in each of the past 5 years.
LRN had a positive operating cash flow in each of the past 5 years.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of LRN (13.56%) is better than 91.78% of its industry peers.
LRN has a Return On Equity of 21.12%. This is amongst the best in the industry. LRN outperforms 87.67% of its industry peers.
LRN has a better Return On Invested Capital (14.55%) than 93.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LRN is below the industry average of 12.00%.
The last Return On Invested Capital (14.55%) for LRN is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROIC 14.55%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 13.10%, LRN belongs to the top of the industry, outperforming 87.67% of the companies in the same industry.
In the last couple of years the Profit Margin of LRN has grown nicely.
The Operating Margin of LRN (16.49%) is better than 82.19% of its industry peers.
In the last couple of years the Operating Margin of LRN has grown nicely.
LRN has a Gross Margin (39.08%) which is comparable to the rest of the industry.
LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LRN is creating some value.
LRN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LRN has more shares outstanding
LRN has a better debt/assets ratio than last year.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.87 indicates that LRN is not in any danger for bankruptcy at the moment.
LRN's Altman-Z score of 7.87 is amongst the best of the industry. LRN outperforms 91.78% of its industry peers.
LRN has a debt to FCF ratio of 2.09. This is a good value and a sign of high solvency as LRN would need 2.09 years to pay back of all of its debts.
The Debt to FCF ratio of LRN (2.09) is better than 80.82% of its industry peers.
LRN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
LRN has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: LRN outperforms 49.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Altman-Z 7.87
ROIC/WACC1.68
WACC8.65%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.61 indicates that LRN has no problem at all paying its short term obligations.
LRN has a better Current ratio (5.61) than 93.15% of its industry peers.
A Quick Ratio of 5.53 indicates that LRN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.53, LRN belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.61
Quick Ratio 5.53
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.47% over the past year.
Measured over the past years, LRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 39.31% on average per year.
The Revenue has grown by 14.90% in the past year. This is quite good.
LRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.97% yearly.
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%

3.2 Future

LRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.07% yearly.
LRN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.53% yearly.
EPS Next Y42.16%
EPS Next 2Y26.21%
EPS Next 3Y22.07%
EPS Next 5YN/A
Revenue Next Year16.66%
Revenue Next 2Y12.43%
Revenue Next 3Y11.29%
Revenue Next 5Y9.53%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.87, LRN is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 63.01% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.82. LRN is around the same levels.
LRN is valuated rather expensively with a Price/Forward Earnings ratio of 20.57.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 64.38% of the companies listed in the same industry.
LRN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.87
Fwd PE 20.57
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LRN is valued a bit cheaper than the industry average as 63.01% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LRN is valued a bit cheaper than the industry average as 65.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.17
EV/EBITDA 12.88
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LRN has an outstanding profitability rating, which may justify a higher PE ratio.
LRN's earnings are expected to grow with 22.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)0.61
EPS Next 2Y26.21%
EPS Next 3Y22.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STRIDE INC

NYSE:LRN (5/23/2025, 8:04:00 PM)

After market: 156.329 +3.33 (+2.18%)

153

-1.39 (-0.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners114.95%
Inst Owner Change-2.46%
Ins Owners2.78%
Ins Owner Change-0.18%
Market Cap6.65B
Analysts82.22
Price Target164.22 (7.33%)
Short Float %10.13%
Short Ratio5.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.39%
Min EPS beat(2)-0.5%
Max EPS beat(2)3.28%
EPS beat(4)3
Avg EPS beat(4)86.24%
Min EPS beat(4)-0.5%
Max EPS beat(4)331.54%
EPS beat(8)7
Avg EPS beat(8)64.82%
EPS beat(12)10
Avg EPS beat(12)21.41%
EPS beat(16)13
Avg EPS beat(16)22.68%
Revenue beat(2)2
Avg Revenue beat(2)2.53%
Min Revenue beat(2)2.13%
Max Revenue beat(2)2.93%
Revenue beat(4)4
Avg Revenue beat(4)3.46%
Min Revenue beat(4)0.58%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)3.08%
Revenue beat(12)11
Avg Revenue beat(12)3.02%
Revenue beat(16)15
Avg Revenue beat(16)3.24%
PT rev (1m)20.15%
PT rev (3m)40.92%
EPS NQ rev (1m)0.99%
EPS NQ rev (3m)0.15%
EPS NY rev (1m)-0.37%
EPS NY rev (3m)-1.05%
Revenue NQ rev (1m)2.42%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)1.35%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE 23.87
Fwd PE 20.57
P/S 2.91
P/FCF 27.17
P/OCF 21.7
P/B 4.69
P/tB 6.75
EV/EBITDA 12.88
EPS(TTM)6.41
EY4.19%
EPS(NY)7.44
Fwd EY4.86%
FCF(TTM)5.63
FCFY3.68%
OCF(TTM)7.05
OCFY4.61%
SpS52.56
BVpS32.59
TBVpS22.65
PEG (NY)0.57
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROCE 19.44%
ROIC 14.55%
ROICexc 23.21%
ROICexgc 36.04%
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
FCFM 10.71%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
ROICexc(3y)14.4%
ROICexc(5y)11.23%
ROICexgc(3y)26.36%
ROICexgc(5y)21.09%
ROCE(3y)12.66%
ROCE(5y)10.14%
ROICexcg growth 3Y21.6%
ROICexcg growth 5Y11.49%
ROICexc growth 3Y26.37%
ROICexc growth 5Y16.18%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
F-Score7
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Debt/EBITDA 0.96
Cap/Depr 54.87%
Cap/Sales 2.7%
Interest Coverage 42.95
Cash Conversion 62.64%
Profit Quality 81.78%
Current Ratio 5.61
Quick Ratio 5.53
Altman-Z 7.87
F-Score7
WACC8.65%
ROIC/WACC1.68
Cap/Depr(3y)62.27%
Cap/Depr(5y)61.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.69%
Profit Quality(3y)114.31%
Profit Quality(5y)120.41%
High Growth Momentum
Growth
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
EPS Next Y42.16%
EPS Next 2Y26.21%
EPS Next 3Y22.07%
EPS Next 5YN/A
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%
Revenue Next Year16.66%
Revenue Next 2Y12.43%
Revenue Next 3Y11.29%
Revenue Next 5Y9.53%
EBIT growth 1Y63.97%
EBIT growth 3Y31.23%
EBIT growth 5Y40.56%
EBIT Next Year96.56%
EBIT Next 3Y33.21%
EBIT Next 5Y23.21%
FCF growth 1Y51.48%
FCF growth 3Y38.43%
FCF growth 5Y18.44%
OCF growth 1Y32.37%
OCF growth 3Y27.61%
OCF growth 5Y14.51%